Advertisement

Advertisement

AZN Stock Latest News

AstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

The FlyAstraZeneca price target lowered to 15,300 GBp at Morgan Stanley

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

PremiumTipRanks Newswire

After Crinetics’ $10 Billion Deal, Could Entera Bio Be the Next Category-Defining Oral Peptide Story?

2d ago

AstraZeneca’s COMETA COPD Trial Nears Key Data Milestone

PremiumCompany Announcements

AstraZeneca’s COMETA COPD Trial Nears Key Data Milestone

2d ago

AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M

PremiumThe Fly

AstraZeneca to acquire rights to develop, commercialize Zegfrovy for $600M

3d ago

AstraZeneca Buys Global Rights to Dizal’s Zegfrovy in $1.5bn Lung Cancer Deal

PremiumCompany Announcements

AstraZeneca Buys Global Rights to Dizal’s Zegfrovy in $1.5bn Lung Cancer Deal

3d ago

Alnylam price target raised to $485 from $470 at H.C. Wainwright

PremiumThe FlyAlnylam price target raised to $485 from $470 at H.C. Wainwright

4d ago

AstraZeneca downgraded to Hold from Buy at HSBC

The Fly

AstraZeneca downgraded to Hold from Buy at HSBC

4d ago

Federal health role nominee has record of vaccine skepticism, Stat News reports

The Fly

Federal health role nominee has record of vaccine skepticism, Stat News reports

6d ago

AstraZeneca price target lowered to 17,500 GBp from 18,000 GBp at Citi

PremiumThe Fly

AstraZeneca price target lowered to 17,500 GBp from 18,000 GBp at Citi

7d ago

Intellia Therapeutics price target raised to $17 from $12 at Wedbush

PremiumThe Fly

Intellia Therapeutics price target raised to $17 from $12 at Wedbush

7d ago

AstraZeneca price target raised to C$190 from C$180 at Stifel

PremiumThe Fly

AstraZeneca price target raised to C$190 from C$180 at Stifel

7d ago

Ionis Pharmaceuticals price target lowered to $95 from $110 at Canaccord

PremiumThe Fly

Ionis Pharmaceuticals price target lowered to $95 from $110 at Canaccord

7d ago

Ionis Pharmaceuticals price target lowered to $100 from $115 at Citi

PremiumThe FlyIonis Pharmaceuticals price target lowered to $100 from $115 at Citi

7d ago

Appeals court upholds win for AstraZeneca in Pfizer patent fight, Reuters says

The Fly

Appeals court upholds win for AstraZeneca in Pfizer patent fight, Reuters says

7d ago

Ionis Pharmaceuticals price target lowered to $86 from $105 at Needham

The Fly

Ionis Pharmaceuticals price target lowered to $86 from $105 at Needham

7d ago

AstraZeneca Sharpens Andexanet Strategy With Completed Phase I Dosing Study

PremiumCompany Announcements

AstraZeneca Sharpens Andexanet Strategy With Completed Phase I Dosing Study

7d ago

AstraZeneca Completes Russian Lupus Study, Building Real-World Data Edge

PremiumCompany Announcements

AstraZeneca Completes Russian Lupus Study, Building Real-World Data Edge

7d ago

AstraZeneca Completes Major Russian CKD Diagnosis Study, Setting Stage for Cardiorenal Growth

PremiumCompany Announcements

AstraZeneca Completes Major Russian CKD Diagnosis Study, Setting Stage for Cardiorenal Growth

7d ago

Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’

PremiumThe Fly

Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’

7d ago

Ionis Pharmaceuticals price target lowered to $94 from $108 at TD Cowen

PremiumThe FlyIonis Pharmaceuticals price target lowered to $94 from $108 at TD Cowen

7d ago

Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That

Market News

Is AstraZeneca (AZN) Stock a Buy on Today’s Dip? Here’s What Analysts Have to Say About That

8d ago

Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results

Market News

Ionis Pharmaceuticals (IONS) Stock Slammed by Phase 3 Trial Results

8d ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >